simvastatin/ezetimibe + atorvastatin 20mg
ApprovedUNKNOWN 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Type 2 Diabetes Mellitus Without Insulin Treatment
Conditions
Type 2 Diabetes Mellitus Without Insulin Treatment
Trial Timeline
Sep 1, 2010 → Aug 1, 2011
NCT ID
NCT01185236About simvastatin/ezetimibe + atorvastatin 20mg
simvastatin/ezetimibe + atorvastatin 20mg is a approved stage product being developed by Merck for Type 2 Diabetes Mellitus Without Insulin Treatment. The current trial status is unknown. This product is registered under clinical trial identifier NCT01185236. Target conditions include Type 2 Diabetes Mellitus Without Insulin Treatment.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01185236 | Approved | UNKNOWN |
Competing Products
20 competing products in Type 2 Diabetes Mellitus Without Insulin Treatment